Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases

Phase 4 Unknown 320 enrolled Nanjing Chia-tai Tianqing Pharmaceutical

NaSingle-groupOpen-labelTreatment

To evaluate the efficacy and safety of Raltitrexed for advanced colorectal cancer

Evaluation	Drug	Modality	Dose	Route
Subject	Oxaliplatin	Small molecule	100 mg	Other
Subject	Oxaliplatin	Small molecule	150 mg	Other
Subject	Raltitrexed	Small molecule	4 mg	Other
Background	lipiodol	Unknown	5 ml	Other
Background	lipiodol	Unknown	20 ml	Other